Pseudomonas aeruginosa infection
Clinical trials for Pseudomonas aeruginosa infection explained in plain language.
Never miss a new study
Get alerted when new Pseudomonas aeruginosa infection trials appear
Sign up with your email to follow new studies for Pseudomonas aeruginosa infection, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can viruses that eat bacteria beat a deadly hospital lung infection?
Disease control Not yet recruitingThis trial tests whether inhaling bacteriophages, which are viruses that specifically kill Pseudomonas aeruginosa bacteria, can help clear a serious lung infection in patients on breathing machines. The study includes adults with ventilator-associated pneumonia caused by this bac…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Virus cocktail takes on superbugs in cystic fibrosis trial
Disease control Not yet recruitingThis early-stage study tests whether adding specially-made viruses (phages) to standard antibiotics can safely treat stubborn lung infections in adults with cystic fibrosis. About 30 participants will receive a 7-day course of both treatments. The main goal is to check safety, bu…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase 1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Personalized antibiotic dosing could save lives in the ICU
Knowledge-focused Not yet recruitingThis study aims to find the best way to dose the antibiotic ceftazidime for patients in intensive care with serious infections. Many ICU patients don't get enough of the drug because their bodies process it differently. The researchers will test a personalized dosing plan to keep…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Blood cancer patients may need higher antibiotic doses to beat superbugs
Knowledge-focused Not yet recruitingThis study looks at whether the standard dose of the antibiotic ceftazidime-avibactam reaches high enough levels in the blood of people with blood cancers or those who have had a stem cell transplant. These patients are at high risk for severe infections from drug-resistant bacte…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Sponsor: Sizhou Feng • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC